Rafael Holdings Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Rafael Holdings Inc's inventory turnover ratio sequentially decreased to 0.66 in the third quarter 2026, unsurprisingly, as the Rafael Holdings Inc markets continue to deteriorate, and RFL's faces growing challenges to bring down its inventories. Rafael Holdings Inc's average inventory processing period in the Apr 30 2026 quarter, has increased to 553 days, from 493 days, in the Jan 31 2026 quarter.

Within Healthcare sector 336 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 0 in the , to 1748.

RFL Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Rafael Holdings Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RFL Inventory Turnover Ratio	(Apr 30 2026) III. Quarter	(Jan 31 2026) 2026	(Oct 31 2025) I. Quarter	(Jul 31 2025) IV. Quarter	(Apr 30 2025) III. Quarter
Y / Y Inventory Growth	-4.17 %	-	-	-	-
Y / Y Cost of Sales Growth	-74.19 %	-68.42 %	-75.68 %	121.74 %	-63.53 %
Inventory Turnover Ratio (TTM)	0.66	0.74	1.1	1.82	2.43
RFL's Total Ranking	# 1748	# 0	# 0	# 0	# 0
Average inventory processing period	552	495	332	200	150
Seq. Inventory Growth	1.85 %	-0.37 %	-3.2 %	-2.43 %	-
Seq. Cost of Sales Growth	-33.33 %	33.33 %	-94.12 %	393.55 %	-18.42 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 102
Healthcare Sector	# 337
Overall Market	# 1748

Inventory Turnover Ratio Statistics
High	Average	Low
0.83	0.78	0.72
(Oct 31 2025)		(Apr 30 2026)

RFL Company Profile >> Back to RFL Efficiency Comparisons >> Compare RFL Inventory Turnover Ratio to its Competitors

Financial Statements
Rafael Holdings Inc's Inventories	$ 0 Millions	Visit RFL's Balance sheet
Rafael Holdings Inc's Cost of Revenues TTM	$ 0 Millions	Visit RFL's Income Statement
What are RFL's Sales?		Visit RFL's Sales by Segment

Other Inventory Turnover Ratios
Rafael Holdings Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RFL's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RFL's Competitors
Inventory Turnover Ratio for RFL's Suppliers
Inventory Turnover Ratio for RFL's Customers

You may also want to know
RFL's Sales Growth Rates	RFL's Pe Price to earnings ratio	RFL's Receivables Turnover Ratio	RFL's Stock Quote
RFL's Net Income Growth Rates	RFL's Ps Price to Sales ratio	RFL's Sales per Employee	RFL's Asset Turnover Ratio
RFL's Net Margin	RFL's Pb Price to Book ratio	RFL's Financial Strength Ratios	RFL's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Apr 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Apr 30 2026	Inventories at quarter ending Apr 30 2026
Immucell Corporation	1.81	$ 16.287 Millions	$ 9 Millions
Cerus Corporation	1.80	$ 101.000 Millions	$ 56 Millions
Sunshine Biopharma Inc	1.77	$ 23.787 Millions	$ 13 Millions
Artivion Inc	1.76	$ 162.000 Millions	$ 92 Millions
Trisalus Life Sciences Inc	1.72	$ 6.000 Millions	$ 3 Millions
Iradimed Corporation	1.72	$ 19.987 Millions	$ 12 Millions
Stryker Corp	1.71	$ 9,139.000 Millions	$ 5,347 Millions
Atricure Inc	1.70	$ 134.000 Millions	$ 79 Millions
Conmed Corporation	1.70	$ 614.344 Millions	$ 362 Millions
Rigel Pharmaceuticals Inc	1.69	$ 19.818 Millions	$ 12 Millions
Quanterix Corporation	1.69	$ 80.528 Millions	$ 48 Millions
Sanuwave Health Inc	1.68	$ 10.312 Millions	$ 6 Millions
Ceribell Inc	1.68	$ 11.000 Millions	$ 7 Millions
The Cooper Companies Inc	1.67	$ 1,457.000 Millions	$ 875 Millions
Masimo Corp	1.66	$ 595.000 Millions	$ 359 Millions
Tenon Medical Inc	1.65	$ 1.617 Millions	$ 1 Millions
Mannkind Corporation	1.64	$ 57.376 Millions	$ 35 Millions
Catheter Precision Inc	1.63	$ 0.094 Millions	$ 0 Millions
Bruker Corporation	1.63	$ 1,891.000 Millions	$ 1,158 Millions
Waters Corporation	1.63	$ 1,297.991 Millions	$ 796 Millions
Procept Biorobotics Corporation	1.63	$ 115.000 Millions	$ 70 Millions
Integra Lifesciences Holdings Corp	1.63	$ 790.340 Millions	$ 486 Millions
Alpha Pro Tech Ltd	1.62	$ 37.000 Millions	$ 23 Millions
Harvard Bioscience Inc	1.61	$ 35.000 Millions	$ 22 Millions
Bio rad Laboratories Inc	1.61	$ 1,246.000 Millions	$ 773 Millions
Cumberland Pharmaceuticals Inc	1.61	$ 7.175 Millions	$ 4 Millions
Haemonetics Corporation	1.60	$ 546.000 Millions	$ 342 Millions
Lexicon Pharmaceuticals Inc	1.59	$ 0.352 Millions	$ 0 Millions
Capsovision Inc	1.56	$ 4.964 Millions	$ 3 Millions
IMPACT BIOMEDICAL INC.	1.55	$ 0.424 Millions	$ 0 Millions

Date modified: 2026-06-12T03:01:44+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.